Synthesis and Solid State Pharmaceutical Centre, Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland.
Int J Pharm. 2017 Feb 25;518(1-2):111-118. doi: 10.1016/j.ijpharm.2016.11.045. Epub 2016 Nov 21.
Nanoparticles of poorly water-soluble drugs were prepared in suspension via antisolvent precipitation in order to improve their dissolution behaviour. Insoluble, surface-functionalized, micron-range, clay carrier particles were employed for the dual purpose of stabilizing the nanoparticles in suspended state, and facilitating their unhindered isolation to solid state; often a challenging step in nanoparticle production. The carrier particles, which were functionalized with an optimal level of cationic polymer (protamine), attracted negatively-charged nanoparticles to their surface as a uniform and segregated nanoparticle layer, at drug loadings up to 9% w/w. By using carrier particles to stabilise the nanoparticles on their surface, the traditionally used solubilised nanosuspension stabilisers could be eliminated, thus avoiding time-consuming stabiliser screening tests. The carrier particle system facilitated stabilisation of nanoparticles in suspension, isolation of nanoparticles to the solid state via filtration, and preservation of fast nanoparticle-induced dissolution rates of the dried nanoparticle-carrier composites, indicating preservation of their high surface area during drying. The process was validated with two poorly water-soluble BCS Class II drugs, fenofibrate and mefenamic acid, both of which demonstrated negative surface charge in aqueous suspension.
为了改善药物的溶解性能,采用抗溶剂沉淀法将疏水性药物制备成混悬液纳米粒子。不溶性、表面功能化、微米级的粘土载体颗粒被用于双重目的:在悬浮状态下稳定纳米粒子,并促进其无阻碍地分离到固体状态;这通常是纳米粒子生产中的一个具有挑战性的步骤。载体颗粒用最佳水平的阳离子聚合物(鱼精蛋白)进行功能化,将带负电荷的纳米粒子吸引到其表面,形成均匀且分离的纳米粒子层,药物载量高达 9%w/w。通过使用载体颗粒在其表面稳定纳米粒子,可以避免使用传统的溶解纳米悬浮液稳定剂,从而避免耗时的稳定剂筛选测试。载体颗粒系统促进了纳米粒子在悬浮液中的稳定,通过过滤将纳米粒子分离到固体状态,并保持干燥纳米粒子-载体复合材料的快速纳米粒子诱导溶解速率,表明在干燥过程中保持了其高表面积。该过程用两种疏水性较差的 BCS 类 II 药物进行了验证,即非诺贝特和甲芬那酸,它们在水混悬液中都表现出负表面电荷。